Understanding how neuropeptides are transported and processed in cells
Mechanisms of intracellular transport and processing of neuropeptides
This study is looking at how tiny messengers in the brain, called neuropeptides, move around and work inside cells, using fruit flies to help us see what's happening, and it could lead to new ways to help people with brain disorders like Alzheimer's.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Middle Tennessee State University NIH-funded |
| Lab location | 1 site (Murfreesboro, United States) |
| Project ID | NIH-10974965 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which neuropeptides, important chemical messengers in the nervous system, are transported and processed within cells. By using genetically modified fruit flies, the study aims to visualize how these neuropeptides are sorted, trafficked, and released from specialized cellular compartments. The findings could provide insights into the biological processes that underlie various neurological disorders, including Alzheimer's disease. The research focuses on understanding the molecular machinery involved in these processes to potentially identify new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with neurodegenerative conditions, particularly Alzheimer's disease.
Not a fit: Patients with non-neurological conditions or those not affected by neurodegenerative diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for neurodegenerative diseases by improving our understanding of neuropeptide function and regulation.
How similar studies have performed: Other research has shown promising results in understanding neuropeptide functions, suggesting that this approach could yield valuable insights.
Where this research is happening
Murfreesboro, United States
- Middle Tennessee State University — Murfreesboro, United States (Active)
Researchers
- Principal investigator: Ormerod, Kiel — Middle Tennessee State University
- Study coordinator: Ormerod, Kiel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.